Black Rock Inc. Tenaya Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,074,056 shares of TNYA stock, worth $9.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,074,056
Previous 4,700,997
13.34%
Holding current value
$9.04 Million
Previous $24.6 Million
48.63%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$20.9 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$15.5 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$14.9 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$7.13 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$6.72 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $91.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...